AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2022
Dec 19, 2022
29871_dirs_2022-12-19_19d01956-ec11-45b8-86d1-af3a51d4ec27.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-12-15
Reporting Person: Tully Sean (Sr MD Global Hd Rates & OTC)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-15 | Common Stock Class A | A | 122 | $155.22 | Acquired | 22087 | Direct |
Footnotes
F1: Reflects shares of CME Group Class A common stock purchased by Mr. Tully in our Employee Stock Purchase Plan ("ESPP") pursuant to his election made on May 19, 2022 for the ESPP purchase period of June 16, 2022 through December 15, 2022. In accordance with the terms of the ESPP, these shares were purchased based on 90% of the closing price of CME Group's Class A common stock on December 15, 2022.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17